SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing significant volatility driven by concerns over its heavy debt load and high AI-related capital expenditures, following a credit downgrade. While many investors are expressing frustration over the recent price decline, a vocal segment of the community views the stock as deeply oversold and is actively accumulating shares, pointing to a massive backlog of contracted AI infrastructure revenue as a long-term catalyst.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is experiencing significant volatility and community attention following the replacement of CEO David Gandler with former Disney executive Alisa Bowen, sparking widespread debate over whether this leadership change signals a long-term turnaround or a precursor to a Disney takeover. Investors remain sharply divided, with many expressing frustration over persistent share price declines while others view the current valuation as an attractive entry point for a potential rebound under new strategic guidance.

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Q32 Bio Inc.

Q32 Bio is trending due to a major asset sale that has investors eyeing the stock's long-term valuation potential alongside a significant surge in trading volume. The community is actively debating the company's prospects for a potential buyout, while day traders capitalize on the stock's high volatility and momentum-driven price action.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amid intense community debate over the company's fundamental valuation versus its speculative trading activity and the broader political controversy surrounding the former president. Investors are actively discussing the stock's volatility in the context of recent geopolitical tensions, executive actions, and divisive social media discourse.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending as traders closely track its price volatility and speculative momentum, fueled by community discussion surrounding the potential of its AXON AI ad engine and the recent launch of its new lifestyle social app, Gist. Investors are debating the stock's future amid sector-wide software rotations, with many pointing to its strong margins and monetization capabilities as catalysts for a potential sustained breakout.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is currently trending as investors navigate heightened geopolitical uncertainty following the reinstatement of an Iranian blockade and new shipping fees in the Strait of Hormuz. Community discussion is heavily divided between bears anticipating a technical correction and bulls who continue to buy the dip, citing persistent market resilience and institutional support for tech leadership.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is currently experiencing significant momentum and investor interest, driven by a series of Medicare coverage milestones for its NeXT Personal MRD test and anticipation for upcoming oncology data readouts. The community is actively debating the company's valuation relative to its high-growth peers and closely watching the scalability of its commercial partnership with Tempus AI as a key catalyst for future revenue.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is surging as renewed military strikes in the Middle East and the official collapse of the U.S.-Iran ceasefire heighten fears of supply disruptions in the Strait of Hormuz. While some community members remain skeptical of geopolitical market manipulation, traders are actively debating the sustainability of the price move as they navigate volatility and evolving risks to global energy flows.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing significant volatility driven by heavy liquidation from leveraged positions and broader concerns surrounding South Korea's KOSPI market rebalancing. Community members are actively debating whether the current price action presents a high-risk dip-buying opportunity or the beginning of a larger correction within the AI-linked memory semiconductor sector.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals is experiencing a surge in community interest driven by strong institutional accumulation and consistent script growth that reinforces the company's path to profitability. Investors are heavily focused on the potential for a short squeeze, citing high short interest and a limited float, while the community remains overwhelmingly bullish on the company's long-term potential for market dominance in the GI sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SLS Vs MLTX: Retail Traders Race To Pick Merck’s Next Biotech Buyout As Keytruda’s $31.7B Patent Cliff Nears

Equity

SLS leads in stock momentum, while MLTX is cheaper and better-funded, with nearly $300 million in cash at the end of the first quarter.

Nasdaq, S&P 500, Dow Futures Fall After Trump Directs Strikes ‘To Hold Iranian Forces Accountable’: NVDA, SLS, MRK, SKHYV, QS Stocks In Focus

U.S. Central Command said that American forces had begun launching further strikes against Iran to thwart their ability “to attack civilian mariners and commercial ships freely transiting the Strait of Hormuz.”

SLS Stock Snaps 2-Day Slide: Sellas’ SLS009 AML Trial Spotlights Big Pharma Drug Combo From ABBV, RHHBY And BMY

SLS009 traces back to Sellas’ 2022 GenFleet licensing deal, when the company obtained rights outside Greater China to GFH009, now known as SLS009.

SLS Stock In The Spotlight As CEO Pushes Back On Regal Trial Criticism – ‘Let’s Separate The Noise From The Data’ 

 CEO Angelos M. Stergiou addressed concerns over the company’s trial to treat acute myeloid leukemia.

SELLAS Life Sciences Shares Slip Wednesday as Price Tests $16 Resistance Wall

SELLAS Life Sciences Group shares are trading lower Wednesday as investors take profits, with risk appetite softer across equities.read more...

SLS Stock Logs 2-Day Losing Streak: Mixed Institutional Bets Emerge Ahead Of Key AML Trial Update 

Gamma Investing cut its SLS stake by 259 shares, or 32%, holding 556 shares worth about $8,210 as of June 30.

SLS Stock Rises Overnight: Why Retail Traders Prefer Sellas Over IBRX, ONDS, PYPL As Most Bullish Pick

Traders are watching for the 80th event, data lock and topline results, while some are also speculating about potential M&A.

SLS Stock Notches 3-Week Winning Run: MassMutual Opens Tiny Stake Ahead Of Key AML Readout 

First Financial Bank also held 10,000 SLS shares, valued at $147,600.

Nasdaq, S&P 500, Dow Futures Rise After Fourth Of July Break As Investors Await Fed Minutes: SLS, ONDS, HOOD, MARA, HUT In Focus

U.S. stock futures edged higher in the overnight session ahead of Monday’s open following a strong rally in the prior week. 

SLS Stock Sees Worst Day In Over A Month — But Prediction Market Flashes 83% Odds For November AML Trial Success 

Endpoint Area listed Nov. 30 as the expected catalyst timing for Sellas’ Phase 3 GPS trial.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Bullish Sentiment

$TMDX

$SLS

Which of these trending stocks are you most tempted to buy - $ON, $TMDX, $SLS, or $BE?

Stocktwits

ON Semiconductor Corp.

Transmedics Group Inc

Bloom Energy Corp - Ordinary Shares - Class A

Which of these trending stocks are you most tempted to buy - 

Stocktwits Polls

Retail investors are fueling heavy speculation regarding an imminent acquisition of the company, specifically linking interest from pharmaceutical giants.

Investors are intensely monitoring clinical trial triggers as the primary catalyst expected to significantly influence share price and valuation.

Data showing a sharp increase in long-only institutional ownership has sparked confidence in a massive structural accumulation trend.

Battle lines are drawn as traders analyze high borrow rates and heavy short interest, anticipating potential volatility from algorithmic manipulation.

Feed

News

Sentiment

Earnings

Fundamentals

Info

SLSSELLAS Life Sciences Group Inc

Fundamentals

Latest SLS News